Evidence map›Paper›PMID 26006021›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2015

Cardioprotection by PI3K-mediated signaling is required for anti-arrhythmia and myocardial repair in response to ischemic preconditioning in infarcted pig hearts.

Feng Su, Lan Zhao, Shaoheng Zhang, Jiahong Wang, Nannan Chen, Qunlin Gong, Jinhui Tang, Hao Wang, Jianhua Yao, Qin Wang and 2 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Feng Su1] Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Department of Cardiology, Qilu Hospital of Shandong University, Ji'nan, People's Republic of China [2] Department of Cardiology, Yangpu Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
Lan ZhaoDepartment of Cardiology, Dahua Hospital, Shanghai, People's Republic of China.
Shaoheng ZhangDepartment of Cardiology, Yangpu Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
Jiahong WangDepartment of Cardiology, Yangpu Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
Nannan ChenDepartment of Cardiology, Yangpu Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
Qunlin GongDepartment of Cardiology, Yangpu Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
Jinhui TangDepartment of Cardiology, Yangpu Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
Hao WangDepartment of Cardiology, Yangpu Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
Jianhua YaoDepartment of Cardiology, Yangpu Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
Qin WangDepartment of Cardiology, Yangpu Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
Ming ZhongKey Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Department of Cardiology, Qilu Hospital of Shandong University, Ji'nan, People's Republic of China.
Jian YanDepartment of Cardiology, Dahua Hospital, Shanghai, People's Republic of China.
Yangpu Hospital of Tongji University · CNDahua Hospital · CNMinistry of Education · THQilu Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the phosphatidyl-inositol-3-kinase (PI3K)/Akt pathway is essential for conferring cardioprotection in response to ischemic preconditioning (IP), the role of PI3K/Akt signaling in the infarcted heart for mediating the anti-arrhythmic effects in response to IP remains unclear. We explored the involvement of PI3K/Akt in the IP-like effect of connexin 43 and proangiogenic factors with particular regard to its role in protecting against ischemia-induced arrhythmia, heart failure, and myocardial remodeling. Groups of pigs were administered phosphate-buffered saline (PBS) or LY294002 solution. Before induction of myocardial infarction (MI), pigs were grouped according to whether or not they underwent IP. Next, all animals underwent MI induction by ligation of the left anterior descending (LAD) coronary artery. Myocardial tissues from the pig hearts at 7 days after MI were used to assess myocardium myeloperoxidase and reaction oxygen species, infarct size, collagen content, blood vascular density, expression of Akt, connexin 43, and proangiogenic growth factors, using spectrophotometer, histology, immunohistochemistry, real-time RT-PCR, and western blot. At 7 days after MI, IP significantly reduced animal mortality and malignant ventricular arrhythmia, myocardial inflammation, infarct size, and collagen content, and improved cardiac function and remodeling; use of the PI3K inhibitor LY294002 diminished these effects. In parallel with a decline in Akt expression and phosphorylation by MI, LY294002 injection resulted in significant suppression of connexin 43 and proangiogenic factor expression, and a reduction of angiogenesis and collateral circulation. These findings demonstrate that the cardioprotective effects of IP on antiventricular arrhythmia and myocardial repair occur through upregulation of PI3K/Akt-mediated connexin 43 and growth factor signaling.

Indexed as

Ischemic PreconditioningAnimalsChromonesMorpholinesMyocardial InfarctionMyocardiumPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsSignal TransductionSwineVascular Endothelial Growth Factor A2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneChromonesMorpholinesPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsVascular Endothelial Growth Factor A

Identifiers

PMID26006021
OpenAlexW1564038992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.